Epratuzumab (Anti-Siglec-2 / CD22), 1mg*25

Epratuzumab (Anti-Siglec-2 / CD22), 1mg*25

Anti-Siglec-2 / CD22 (NCI m971), 1mg*5

Anti-Siglec-2 / CD22 (NCI m971), 1mg*5

Anti-Siglec-2 / CD22 (NCI m971), 1mg

3.700,90 RON
SKU
SKM_A3057_1mg

Anti-Siglec-2 / CD22 (NCI m971) is a humanized monoclonal antibody targeting CD22, a Siglec family lectin present on B cells. It is used in treatment of acute lymphoblastic leukemia (ALL). MW :146.64 KD.

Mai multe informatii
Price 3.110,00 RON (preturile sunt fara TVA)
Description

Anti-Siglec-2 / CD22 (NCI m971) is a humanized monoclonal antibody targeting CD22, a Siglec family lectin present on B cells. It is used in treatment of acute lymphoblastic leukemia (ALL). MW :146.64 KD.